Blackstone’s RVL Pharmaceuticals RVLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-632,264
Closed -$56.9K – 184
2023
Q3
$56.9K Buy
+632,264
New +$182K ﹤0.01% 151

Other funds holding RVLP

Blackstone's RVLP Position: Q4 2023 in Review

Blackstone sold out of RVL Pharmaceuticals (RVLP) in Q4 2023, closing a stake of 632,264 shares — an estimated $56.9K sold.

Blackstone first reported a position in RVLP in Q3 2023 and held it in 1 quarter. The position peaked at $56.9K in Q3 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Blackstone reported no remaining RVL Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Blackstone sold 632,264 RVL Pharmaceuticals shares in Q4 2023, an estimated $56.9K.
  • Blackstone first reported a position in RVL Pharmaceuticals in Q3 2023 and held it in 1 quarter.
  • Blackstone's RVL Pharmaceuticals position peaked at $56.9K in Q3 2023.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals as of Q4 2023.

Based on Blackstone's 13F filing for Q4 2023, filed 14 Feb 2024.